Menu
The national stimulant shortages that started with Adderall in the Fall of 2022 continue to wreak havoc on patients and our practices. CSAP and the five California District Branches (CCPS, NCPS, SCPS, OCPS, SDPS) have continued to advocate on this issue
The Public Policy Institute of California (PPIC) just released the results of their most recent statewide survey, Californians and Their Government. The survey findings include that “Fifty-nine percent of likely voters say they would vote yes, and 38 percent would vote
CSAP has a new sponsored bill, SB 1184 (Eggman), which is now in print. SB 1184 proposes to modify Welfare and Institutions Code (WIC) 5336 (Riese Hearings) such that the timeframe covered by judicial determination of incapacity to refuse treatment with antipsychotic medication
